Stay in touch
Be first to hear about developments in our technology platform and get access to early release and evaluation opportunities.

Interview with Becca Farn, Head of Production and Test
Becca has over ten years of experience in product development, specialising in leading multidisciplinary engineering...

Evonetix delivers first chip-synthesized DNA to the University of Cambridge
First delivery and use of DNA manufactured using Evonetix’s unique thermally controlled synthesis technology Key...

Interview with Dr Matthew Hayes, Chief Technology Officer
Dr Matthew Hayes is the Chief Technology Officer of Evonetix and was a founding member of the team that established...

Team Talk – Daniel Bygrave, Group Head of Software
Head of Software, Dan, joined Evonetix at its founding in 2015. Previously, Dan worked as a Principal Software...

Evonetix closes $24 million USD (£20 million) financing
• Oversubscribed round led by Foresite Capital • Funding will enable development of DNA synthesis chip technology to...

Team Talk – Dr Vijay Narayan, Head of Physics
Head of Physics, Vijay, joined Evonetix in 2018 as a Senior Engineer. Prior to this role, Vijay was a Research Fellow...

Team Talk – Dr Stuart Crosby, Head of Synthetic Chemistry
Dr Stuart Crosby has over 20 years’ research experience working in the fields of synthetic chemistry and drug...

Evonetix shortlisted for MSD’s Innovation Award at this year’s Scrip Awards
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, has been...

Evonetix announces early access program for semiconductor synthesized DNA
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today...

Colin McCracken joins Evonetix as Chief Executive Officer
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today...

Evonetix wins The Award for Innovation at Cambridge Independent Science and Technology Awards 2022
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, has...

Evonetix granted patents for novel gene assembly method
IP covers novel method for assembly and error removal in DNA synthesis on silicon chips Patented technology will...

Evonetix appoints Paul Beastall as Chair of Board of Directors
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today...

Evonetix granted patent for technology enabling thermally-controlled DNA synthesis
IP covers proprietary thermally-controlled synthesis chemistry, as well as design and manufacture of silicon chips...

Join us at Built With Biology, SynBioBeta’s global synthetic biology conference. April 12th to 14th, 2022.
We are proud to sponsor SynBioBeta's global synthetic biology conference "Built With Biology" at Oakland from April...


